Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

34.75
+0.20000.58%
Post-market: 34.810.0600+0.17%19:30 EDT
Volume:5.44M
Turnover:187.00M
Market Cap:21.69B
PE:27.47
High:35.02
Open:34.39
Low:33.73
Close:34.55
52wk High:35.91
52wk Low:23.62
Shares:624.06M
Float Shares:617.00M
Volume Ratio:1.25
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.64
PE(LYR):22.61

Loading ...

Genmab is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 02

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 02

Abbvie, Genmab Blood-cancer Drug Has Competitive Profile

Dow Jones
·
Jun 30

Investors See European Pharma Stocks as Funding Source for AI Trades

Dow Jones
·
Jun 30

Guggenheim Reaffirms Their Buy Rating on Genmab (GMAB)

TIPRANKS
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 30

Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial

Dow Jones
·
Jun 30

Abbvie, Genmab's Lymphoma Treatment Meets Primary Endpoint in Phase 3 Trial

Dow Jones
·
Jun 30

Genmab announces topline results from EPCORE DLBCL-4 trial

TIPRANKS
·
Jun 30

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 30

Genmab A/S Stock Falls Friday

Dow Jones
·
Jun 27

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 25

Genmab Price Target Maintained With a $38.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 23

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 23

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jun 18

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Dianthus Therapeutics (DNTH) and Aurora Cannabis (ACB)

TIPRANKS
·
Jun 15

Genmab announces new data from studies evaluating epcoritamab

TIPRANKS
·
Jun 15

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 12